Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis
Conclusion: Patients with oesophagus or GOJ carcinomas can obtain a survival advantage from neoadjuvant CRT. The addition of radiation was efficacy and safe in range. However, these results need further high-quality prospective RCTs confirmation.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Xiangyu Meng, Lu Wang, Yan Zhao, Bo Zhu, Ting Sun, Tao Zhang, Xiaohu Gu, Zhichao Zheng Tags: Research Paper Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Oesophagus | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study